Communication Goes Both Ways
Current research describes the gut–skin relationship as bidirectional. Researchers are examining how microbial communities and host biology at one barrier site may influence signalling involving another.
Researchers are studying how the gut microbiome, immune system, intestinal barrier and skin communicate through what is often called the gut–skin axis. A stool-based gut microbiome test can add educational information to that research journey, but it cannot tell you why you have acne, eczema, psoriasis, a rash or another skin problem.
Can a microbiome test help you understand skin health? It can provide educational information about your gut microbiome that you can consider while learning about the gut–skin axis. Research supports biological communication between the gut and skin, but current consumer gut microbiome testing cannot determine that your stool microbiome caused a breakout, rash or diagnosed skin condition.
The gut–skin axis is a research framework for studying communication between the gastrointestinal tract and skin. It does not mean the two sites contain the same microorganisms or that one consumer stool sample can diagnose a skin disorder.
Current research describes the gut–skin relationship as bidirectional. Researchers are examining how microbial communities and host biology at one barrier site may influence signalling involving another.
The intestinal tract and skin are both barrier surfaces that interact with microorganisms and the immune system. Immune signalling, barrier function and microbial metabolites are among the mechanisms being investigated.
Studies may find microbiome differences in groups with particular skin conditions. That type of association does not prove that one person's gut microbiome caused their individual skin symptoms.
A gut microbiome test using a stool sample examines material from the gastrointestinal environment. It does not directly collect or analyze microorganisms living on the face, scalp, chest, hands or another area of skin.
The gut–skin axis gives researchers a reason to investigate possible relationships between the two environments. It does not make a stool-based test equivalent to a skin swab or dermatology assessment.
Before ordering: decide whether your real goal is learning about your gut microbiome or finding the cause of a skin problem. Those are different questions and may require different next steps.
If skin health is what brought you to microbiome testing, begin with the information the report actually presents rather than searching for a hidden acne, eczema or psoriasis diagnosis.
Depending on the selected test and its reporting method, your report may identify microorganisms or microbial groups detected from the analyzed stool sample.
A report may discuss microbiome diversity or related measures. A diversity value should not be treated as a direct skin-health score or proof that your skin is healthy or unhealthy.
Reports may describe how microbial groups are represented relative to one another. Those patterns can help you learn about the sample, but they do not prove why a skin symptom is present.
Explanations surrounding the findings may help you understand microbiome terminology, research questions and broader diet or lifestyle topics without turning the report into a treatment plan.
The distinction between microbiome education and dermatology is especially important on a symptom-related page.
These conditions have different biology, triggers and treatment pathways. Gut–skin research can add scientific context, but grouping every skin condition under one “microbiome imbalance” explanation would overstate what the evidence can show for an individual.
Researchers are studying relationships involving the gut microbiome, skin microbiome, immunity and acne. A stool microbiome result cannot determine that one gut microorganism caused your acne or replace an acne assessment.
Atopic dermatitis research includes immune function, skin barrier biology, skin microorganisms and possible gut–skin interactions. Consumer stool testing is not an eczema diagnostic test.
The gut–skin axis is also studied in inflammatory conditions such as psoriasis. Current research interest does not mean an at-home stool report can diagnose psoriasis or choose psoriasis treatment.
If your real goal is identifying a persistent or worsening skin condition, finding the cause of a new skin change, preventing scarring, or choosing medical treatment, a regulated healthcare professional is the more appropriate starting point.
In Canada, dermatologists are medical specialists trained to diagnose and treat diseases affecting the skin, hair and nails. Microbiome research can complement scientific understanding, but it does not replace that clinical role.
If a breakout, rash, patch, lesion or other skin change is not settling or is getting worse, seek appropriate assessment rather than waiting for a consumer microbiome result.
Questions such as “Is this acne?”, “Do I have eczema?” or “Could this be psoriasis?” require clinical evaluation rather than interpretation of stool microorganisms.
Do not start, stop or change prescribed skin treatment because of a consumer microbiome report without discussing the decision with the healthcare professional responsible for your care.
Use these four checks to separate microbiome curiosity from a dermatology question that needs a different pathway.
Start with the main gut microbiome test in Canada arrow_forward and check whether its stool-based educational output fits your reason for testing.
Review how at-home microbiome testing works arrow_forward so ordering, sample collection and report access do not come as a surprise.
If you mainly want microbiome education, the report may fit. If you want the cause of acne, eczema, psoriasis, a rash or another skin condition, choose the appropriate healthcare path instead.
At-home testing can involve personal information, a biological sample and report data. Review microbiome testing privacy and data arrow_forward before returning a sample.
Scientific interest in the gut–skin axis is real. A 2025 review involving researchers from BC Children's Hospital and the University of British Columbia describes bidirectional communication between the gastrointestinal tract and skin and discusses microbiota, immune signalling and barrier biology.
At the same time, international expert consensus continues to emphasize important limitations around the current clinical usefulness of commercial microbiome testing. That is why this page treats a stool microbiome report as educational information rather than a dermatology diagnostic test.
Replace author and reviewer placeholders only with real, verifiable information. Do not imply physician, dermatologist, dietitian or scientific review unless that review actually occurred.
The Gut–Skin Axis: A Bi-Directional, Microbiota-Driven Relationship
2025 review with BC Children's Hospital and University of British
Columbia affiliation examining microbiota, barrier biology and
gut–skin signalling.
International Consensus Statement on Microbiome Testing
Expert consensus covering evidence, reporting standards and
limitations of current microbiome testing in clinical practice.
Canadian Dermatology Association
Canadian information about the role of dermatologists in
recognizing, diagnosing and treating diseases of the skin.
Health Canada: Medical Test Kits for Home Use
General Canadian guidance emphasizing test limitations,
correct use and the role of professional healthcare.
Office of the Privacy Commissioner of Canada
Canadian resources covering privacy considerations for health
and body-related information.
These answers separate what gut–skin research is exploring from what an at-home stool microbiome test can establish for an individual.
No. Researchers are studying relationships involving the gut, skin microbiome, immunity and acne, but a consumer stool microbiome report cannot establish the cause of an individual's acne. Acne has multiple biological influences, so diagnosis and treatment decisions should be based on appropriate clinical assessment rather than one gut microbiome pattern.
No. Gut and skin microbial communities are being researched in relation to atopic dermatitis, but an at-home gut microbiome test is not an eczema diagnostic test. If you have persistent or worsening itchy, inflamed or otherwise concerning skin, seek appropriate healthcare assessment instead of relying on a stool report for diagnosis.
The gut–skin axis is a research concept describing biological communication between the gastrointestinal tract and skin. Current research examines gut and skin microbiota, immune signalling, barrier function and microbial metabolites as parts of this relationship. The concept does not mean a stool sample directly measures the microbiome living on your skin.
No. Gut and skin microbiomes exist in different biological environments. A stool-based gut microbiome test analyzes material from the gastrointestinal environment; it does not directly sample microorganisms on your face, scalp or another skin site. Gut–skin research studies relationships between these systems without treating them as the same microbiome.
No. Researchers are investigating microbiome and immune relationships in psoriasis, but a consumer stool report cannot establish that psoriasis originated from your gut or that a particular microorganism caused it. Psoriasis is a medical skin condition that requires appropriate clinical diagnosis and treatment rather than cause-and-effect conclusions from stool data.
No consumer microbiome report can guarantee that one food, elimination diet or dietary change will clear a skin condition. Food and lifestyle information in a report should be treated as educational context. Avoid making unnecessary restrictive changes solely because of a microbiome result, especially when a diagnosed skin condition or nutritional concern is involved.
Seek appropriate healthcare assessment when your main goal is diagnosing a persistent or worsening skin problem, choosing treatment, evaluating a significant new skin change or managing a condition that is not improving. Consumer gut microbiome testing may provide educational information, but it should not delay dermatology or other medical care when that is what you need.
If your goal is microbiome education and the report format fits what you want to learn, at-home gut testing may be a useful next step. If your goal is diagnosing or treating a skin condition, use the appropriate clinical pathway instead.